Icon

VELBAN (nda012665)- (10MG/VIAL)

VINBLASTINE SULFATE LILLY
10MG/VIAL
No No
Expired Expired
None None
None No
Vinblastine Sulfate Injection is indicated in the palliative treatment of the following: I. Frequently Responsive Malignancies *Generalized Hodgkin’s disease (Stages III and IV, Ann Arbor modification of Rye staging system) *Lymphocytic lymphoma (nodular and diffuse, poorly and well differentiated) *Histiocytic lymphoma *Mycosis fungoides (advanced stages) *Advanced carcinoma of the testis *Kaposi’s sarcoma *Letterer-Siwe disease (histiocytosis X) II. Less Frequently Responsive Malignancies *Choriocarcinoma resistant to other chemotherapeutic agents *Carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy.
2 0 1
Total Other Developers None
Drugs with Suitability No
10MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* **** *** ********* **** ***, *** *********** **** *. **** ****** **** ***** ********* ******, ******* ****, ******** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.